pubmed.ncbi.nlm.nih.gov

Hepatitis C virus envelope proteins bind lactoferrin - PubMed

Hepatitis C virus envelope proteins bind lactoferrin

M Yi et al. J Virol. 1997 Aug.

Abstract

Hepatitis C virus (HCV) has two envelope proteins, E1 and E2, which form a heterooligomer. During dissection of interacting regions of HCV E1 and E2, we found the presence of an interfering compound or compounds in skim milk. Here we report that human as well as bovine lactoferrin, a multifunctional immunomodulator, binds two HCV envelope proteins. As determined by far-Western blotting, the bacterially expressed E1 and E2 could bind lactoferrin in human milk directly separated or immunopurified and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The bindings of lactoferrin and HCV envelope proteins in vitro were confirmed by another method, the pull-down assay, with immunoprecipitated lactoferrin-bound protein A resin. By the same assay, mammal-expressed recombinant E1 and E2 were also demonstrated to bind human lactoferrin efficiently in vitro. Direct interaction between E2 and lactoferrin was proved in vivo, since anti-human lactoferrin antibody efficiently coimmunoprecipitated with secreted and intracellular forms of the E2 protein, but not glutathione S-transferase (GST), from lysates of HepG2 cells transiently cotransfected with the expression plasmids of human lactoferrin and gE2t-GST (the N-terminal two-thirds of E2 fused to GST) or GST. The N-terminal loop of lactoferrin, the region important for the antibacterial activity, has only a little role in the binding ability to HCV E2 but affected the secretion or stability of lactoferrin. Taken together, these results indicate the specific interaction between lactoferrin and HCV envelope proteins in vivo and in vitro.

PubMed Disclaimer

Cited by

Combined use of lactoferrin and vitamin D as a preventive and therapeutic supplement for SARS-CoV-2 infection: Current evidence.
Cipriano M, Ruberti E, Tovani-Palone MR. Cipriano M, et al. World J Clin Cases. 2022 Nov 16;10(32):11665-11670. doi: 10.12998/wjcc.v10.i32.11665. World J Clin Cases. 2022. PMID: 36405280 Free PMC article. Review.
Cow Milk Lactoferrin Possesses Several Catalytic Activities.
Soboleva SE, Sedykh SE, Alinovskaya LI, Buneva VN, Nevinsky GA. Soboleva SE, et al. Biomolecules. 2019 May 29;9(6):208. doi: 10.3390/biom9060208. Biomolecules. 2019. PMID: 31146486 Free PMC article.
Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.
El-Fakharany EM, Sánchez L, Al-Mehdar HA, Redwan EM. El-Fakharany EM, et al. Virol J. 2013 Jun 19;10:199. doi: 10.1186/1743-422X-10-199. Virol J. 2013. PMID: 23782993 Free PMC article.
Fluid-Phase Endocytosis and Lysosomal Degradation of Bovine Lactoferrin in Lung Cells.
Sayers EJ, Palmer I, Hope L, Hope P, Watson P, Jones AT. Sayers EJ, et al. Pharmaceutics. 2022 Apr 13;14(4):855. doi: 10.3390/pharmaceutics14040855. Pharmaceutics. 2022. PMID: 35456688 Free PMC article.
Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study.
Tanaka K, Ikeda M, Nozaki A, Kato N, Tsuda H, Saito S, Sekihara H. Tanaka K, et al. Jpn J Cancer Res. 1999 Apr;90(4):367-71. doi: 10.1111/j.1349-7006.1999.tb00756.x. Jpn J Cancer Res. 1999. PMID: 10363572 Free PMC article. Clinical Trial.

References

1. Hepatology. 1992 Sep;16(3):619-24 - PubMed
1. Virology. 1997 Apr 28;231(1):119-29 - PubMed
1. Ann Intern Med. 1992 Dec 1;117(11):887-90 - PubMed
1. J Virol. 1993 Mar;67(3):1385-95 - PubMed
1. J Virol. 1993 Jul;67(7):3923-30 - PubMed

Hepatitis C virus envelope proteins bind lactoferrin - PubMed